Key molecular pathways linking hypertension‐induced inflammation to cancer include NF‐κB activation, prostaglandin overproduction via cyclooxygenase −2 (COX‐2), and disruption of tumor suppressor genes such as p53. The gene discussed is PTGS2; the disease is hypertensive disorder.